LGALS9 and COVID-19: To investigate the potential of plasma N-cleaved-Gal9 as a severity marker for COVID-19, we performed a receiver operating characteristic (ROC) curve analysis and compared the area under the curve (AUC) values of plasma Tr-Gal9 and N-cleaved-Gal9 levels for discriminating CV from CP.